The Filing Desk

Legend Biotech vs Novavax

Legend Biotech LEGN · Novavax NVAX · Biotechnology

Novavax reported revenue of $1.1 billion in fiscal 2025, about the same as Legend Biotech's $1.0 billion in fiscal 2025. Legend Biotech's revenue grew 64.0% in its latest year, and Novavax's grew 64.7%. Legend Biotech had an operating margin of -13.3%, against 40.3% at Novavax. Free cash flow was −$129 million at Legend Biotech and −$250 million at Novavax.

Side by side

Legend BiotechNovavax
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$1.0B$1.1B
Revenue growth64.0%64.7%
Revenue growth a year, last 5 years68.8%18.8%
Gross margin61.4%93.5%
Operating margin−13.3%40.3%
Net margin−28.9%39.2%
Free cash flow−$129M−$250M
Free cash flow margin−12.5%−22.3%
Return on capital−14.6%—
Net debt to EBITDA—−1.0x
Dividends and buybacks$0M$0M
Change in diluted share count0.8%13.7%
Last close$16.10$7.72
P/E at the last close——
Insider trades, last 12 monthssold $307,834—
Piotroski F-score2 of 95 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Legend BiotechNovavax
Operating margin
Percent of revenue
Legend BiotechNovavax
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Legend BiotechNovavax

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Legend Biotech and Novavax pages.